Condition
Therapy Adverse Effect
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed3
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06581497Completed
ICIs With and Without MWA in Advanced Hepatocellular Carcinoma
NCT03566966Completed
Autoantibodies and Direct-acting Antivirals
NCT03751410Completed
Chronic Ibrutinib Therapy Effect on Left Atrial Function
NCT03064880Not ApplicableUnknownPrimary
Preoperative Goal-directed Fluid Therapy and Physiological Changes Following One-lung Ventilation
Showing all 4 trials